Vanderbilt University signed an option and limited license agreement with KIYATEC, a company dedicated to commercializing 3D cell culture technologies.
The Wall Street Journal recently featured “organs on a chip”, an innovative practice that is helping researchers around the globe dive into a new world of drug discovery.